Stocks
Clover Health Investments Financial Statements (CLOV) |
||||||||||
| Clover Health Investmentssmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.12.2019 | 31.03.2021 | 28.02.2022 | 01.03.2023 | 14.03.2024 | 07.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 462.3 | 672.9 | 1 472 | 3 477 | 2 029 | 1 844 | |||
| Operating Income, bln rub | -183.2 | -92.7 | -637.0 | -370.9 | -208.5 | -195.5 | ||||
| EBITDA, bln rub | ? | -182.6 | -92.2 | -635.7 | -369.7 | -180.2 | -172.8 | |||
| Net profit, bln rub | ? | -402.8 | -148.7 | -604.7 | -305.4 | -213.4 | -131.1 | |||
| OCF, bln rub | ? | -159.9 | -2.23 | -282.3 | -203.9 | -115.9 | -291.9 | |||
| CAPEX, bln rub | ? | 0.023 | 0.693 | 0.723 | 4.47 | 0.584 | 0.952 | |||
| FCF, bln rub | ? | -159.9 | -2.92 | -283.0 | -208.4 | -116.5 | -292.4 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 195.8 | 175.1 | 557.8 | 393.7 | 447.2 | 829.9 | ||||
| Cost of production, bln rub | 449.7 | 590.5 | 1 551 | 3 454 | 1 776 | 1 196 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 39.1 | 57.1 | 16.9 | 1.36 | 0.007 | 0.000 | ||||
| Assets, bln rub | 0.100 | 267.3 | 950.8 | 808.6 | 570.7 | 671.8 | ||||
| Net Assets, bln rub | ? | -0.018 | -568.4 | 539.3 | 347.7 | 286.4 | 292.5 | |||
| Debt, bln rub | 57.9 | 0.806 | 27.8 | 5.86 | 4.66 | 4.34 | ||||
| Cash, bln rub | 67.6 | 151.1 | 791.2 | 555.3 | 242.7 | 343.1 | ||||
| Net debt, bln rub | -9.68 | -150.3 | -763.4 | -549.4 | -238.0 | -338.8 | ||||
| Ordinary share price, rub | 16.8 | 3.72 | 0.930 | 0.952 | 1.01 | |||||
| Number of ordinary shares, mln | 103.5 | 88.7 | 412.9 | 476.2 | 482.2 | 486.4 | ||||
| Market cap, bln rub | 0 | 1 487 | 1 536 | 443 | 459 | 491 | ||||
| EV, bln rub | ? | -10 | 1 337 | 773 | -107 | 221 | 152 | |||
| Book value, bln rub | -4 | -573 | 535 | 328 | 283 | 292 | ||||
| EPS, rub | ? | -3.89 | -1.68 | -1.46 | -0.64 | -0.44 | -0.27 | |||
| FCF/share, rub | -1.54 | -0.03 | -0.69 | -0.44 | -0.24 | -0.60 | ||||
| BV/share, rub | -0.04 | -6.46 | 1.30 | 0.69 | 0.59 | 0.60 | ||||
| EBITDA margin, % | ? | -39.5% | -13.7% | -43.2% | -10.6% | -8.88% | -9.37% | |||
| Net margin, % | ? | -87.1% | -22.1% | -41.1% | -8.78% | -10.5% | -7.11% | |||
| FCF yield, % | ? | -0.20% | -18.4% | -47.1% | -25.4% | -59.5% | ||||
| ROE, % | ? | 2 284 641% | 26.2% | -112.1% | -87.8% | -74.5% | -44.8% | |||
| ROA, % | ? | -401 416% | -55.6% | -63.6% | -37.8% | -37.4% | -19.5% | |||
| P/E | ? | 0.00 | -10.0 | -2.54 | -1.45 | -2.15 | -3.75 | |||
| P/FCF | 0.00 | -509.3 | -5.43 | -2.12 | -3.94 | -1.68 | ||||
| P/S | ? | 0.00 | 2.21 | 1.04 | 0.13 | 0.23 | 0.27 | |||
| P/BV | ? | 0.00 | -2.60 | 2.87 | 1.35 | 1.62 | 1.68 | |||
| EV/EBITDA | ? | 0.05 | -14.5 | -1.22 | 0.29 | -1.23 | -0.88 | |||
| Debt/EBITDA | 0.05 | 1.63 | 1.20 | 1.49 | 1.32 | 1.96 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 0.00% | 0.10% | 0.05% | 0.13% | 0.03% | 0.05% | ||||
| Clover Health Investments shareholders | ||||||||||
